Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

570
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
570
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

239
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pain and neuropsychiatric symptoms in community-dwelling people living with dementia: a cross-sectional dyadic study.

BMC geriatrics·2026
Same author

What barriers need to be removed to incorporate resistance exercise into the lives of older adults with long-term diabetes and prefrailty? A deductive framework analysis using the Capability, Opportunity, Motivation and Behaviour (COM-B) behavioural science model.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Preventing Severe Hypoglycemia in Type 2 Diabetes: Randomized Controlled Trial of Proactive Care With Versus Without Psychoeducation.

Journal of general internal medicine·2026
Same author

Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

The Content of Major Haemorrhage Protocols (MHP) in Public Hospitals Throughout Queensland-Are We Following the Evidence?

Emergency medicine Australasia : EMA·2026
Same author

Are amblyopia therapy outcomes related to socioeconomic situation for children in Greater Manchester?

Eye (London, England)·2026

Related Experiment Video

Updated: Dec 20, 2025

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

65.5K

Donor insulin use predicts beta-cell function after islet transplantation.

Iestyn M Shapey1,2, Angela Summers1,2, Petros Yiannoullou1,2

  • 1Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.

Diabetes, Obesity & Metabolism
|May 27, 2020
PubMed
Summary

Donor insulin use (DIU) predicts reduced beta-cell function post-islet transplantation. This finding may improve donor selection and islet transplant outcomes, highlighting the importance of managing donor glucose levels.

Keywords:
insulinisletorgan donorpancreastransplant

More Related Videos

Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

10.0K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

10.6K

Related Experiment Videos

Last Updated: Dec 20, 2025

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation
17:42

A Method for Murine Islet Isolation and Subcapsular Kidney Transplantation

Published on: April 13, 2011

65.5K
Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

10.0K
Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
11:57

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Published on: July 23, 2017

10.6K

Area of Science:

  • Endocrinology
  • Transplantation Immunology
  • Metabolic Research

Background:

  • Insulin manages hyperglycemia in organ donors and peri-transplant islet recipients.
  • The impact of donor insulin use (DIU) on post-transplant beta-cell function is not well understood.

Purpose of the Study:

  • To investigate whether donor insulin use (DIU) predicts beta-cell dysfunction after islet transplantation.

Main Methods:

  • Retrospective review of UK Transplant Registry and Islet Transplant Consortium data (2008-2016).
  • Analysis of 91 first-time islet cell transplant recipients.
  • Linear regression models assessed associations between DIU, peri-transplant glucose metrics, and 3-month graft function.

Main Results:

  • DIU was linked to lower islet function (BETA-2 scores), higher 3-month HbA1c, and lower fasting C-peptide levels.
  • Peri-transplant median glucose levels and glucose coefficient of variation (CV) did not predict transplant outcomes.
  • Analysis included 10,512 glucose measurements during the first 5 peri-transplant days.

Conclusions:

  • Donor insulin use is a predictor of beta-cell dysfunction 3 months post-islet transplantation.
  • DIU data can potentially enhance donor selection criteria and improve islet transplant success rates.